Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Facilities Industry Analysis

UpdatedApr 05, 2026
DataAggregated Company Financials
Companies31
  • 7D-0.8%
  • 3M-6.6%
  • 1Y23.3%
  • YTDn/a

Last week, the Healthcare Facilities industry hasn't moved much but PACS Group is up 5.1% in that time. As for the the longer term, the industry is up 23% over the past 12 months. As for the next few years, earnings are expected to grow by 13% per annum.

Industry Valuation and Performance

Has the U.S. Healthcare Facilities Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 05 Apr 2026US$67.9bUS$80.1bUS$3.4b14.8x19.9x0.8x
Tue, 03 Mar 2026US$78.4bUS$80.5bUS$3.4b16.7x23x1x
Thu, 29 Jan 2026US$68.8bUS$78.9bUS$4.3b17.8x15.9x0.9x
Sat, 27 Dec 2025US$73.1bUS$78.9bUS$4.3b16.9x16.9x0.9x
Mon, 24 Nov 2025US$72.0bUS$78.8bUS$4.3b17.1x16.6x0.9x
Wed, 22 Oct 2025US$72.6bUS$75.4bUS$4.3b17.6x16.9x1x
Fri, 19 Sep 2025US$66.9bUS$74.7bUS$4.2b17.9x15.8x0.9x
Sun, 17 Aug 2025US$65.3bUS$74.7bUS$4.3b17.6x15.3x0.9x
Tue, 15 Jul 2025US$65.8bUS$73.3bUS$4.1b15.7x16x0.9x
Thu, 12 Jun 2025US$63.6bUS$73.3bUS$4.1b16.4x15.5x0.9x
Sat, 10 May 2025US$62.5bUS$73.2bUS$4.2b17.2x14.8x0.9x
Mon, 07 Apr 2025US$56.7bUS$72.5bUS$5.8b16x9.7x0.8x
Wed, 05 Mar 2025US$59.8bUS$73.0bUS$5.7b17.2x10.5x0.8x
Fri, 31 Jan 2025US$64.5bUS$73.8bUS$5.7b17.3x11.4x0.9x
Sun, 29 Dec 2024US$61.0bUS$73.8bUS$5.7b15x10.8x0.8x
Tue, 26 Nov 2024US$69.1bUS$73.7bUS$5.7b18.8x12.2x0.9x
Thu, 24 Oct 2024US$77.5bUS$72.3bUS$4.9b21.8x15.9x1.1x
Sat, 21 Sep 2024US$81.7bUS$72.3bUS$4.9b22x16.8x1.1x
Mon, 19 Aug 2024US$77.3bUS$72.2bUS$4.9b21.6x15.9x1.1x
Wed, 17 Jul 2024US$64.2bUS$63.6bUS$4.4b24x14.7x1x
Fri, 14 Jun 2024US$63.7bUS$63.6bUS$4.4b22.1x14.6x1x
Sun, 12 May 2024US$62.0bUS$63.3bUS$4.3b22.5x14.3x1x
Tue, 09 Apr 2024US$56.7bUS$61.9bUS$1.8b21.2x31.2x0.9x
Thu, 07 Mar 2024US$55.5bUS$60.8bUS$1.9b21.5x29.1x0.9x
Sat, 03 Feb 2024US$54.1bUS$61.3bUS$1.7b20.4x31.5x0.9x
Mon, 01 Jan 2024US$50.3bUS$61.1bUS$1.8b19.6x28.6x0.8x
Wed, 29 Nov 2023US$47.1bUS$61.1bUS$1.8b19.6x26.8x0.8x
Fri, 27 Oct 2023US$42.1bUS$63.5bUS$1.7b20.6x24.8x0.7x
Sun, 24 Sep 2023US$46.0bUS$63.1bUS$1.7b21.4x27x0.7x
Tue, 22 Aug 2023US$48.1bUS$63.6bUS$1.7b22.4x28.3x0.8x
Thu, 20 Jul 2023US$52.5bUS$62.2bUS$1.5b24.6x34.1x0.8x
Sat, 17 Jun 2023US$51.4bUS$62.2bUS$1.5b23.4x33.4x0.8x
Mon, 15 May 2023US$47.9bUS$62.2bUS$1.5b22x31.3x0.8x
Wed, 12 Apr 2023US$47.7bUS$61.1bUS$1.5b24.6x31.7x0.8x
Price to Earnings Ratio

31.7x


Total Market Cap: US$47.7bTotal Earnings: US$1.5bTotal Revenue: US$61.1bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Facilities Industry Price to Earnings3Y Average 20.2x202420252026
Current Industry PE
  • Investors are relatively neutral on the American Health Care Facilities industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 20.2x.
  • The industry is trading close to its 3-year average PS ratio of 0.89x.
Past Earnings Growth
  • The earnings for companies in the Health Care Facilities industry have grown 31% per year over the last three years.
  • Revenues for these companies have grown 9.5% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Healthcare Facilities compare with similar industries?

US Market3.46%
Healthcare3.50%
Healthcare Services4.45%
Healthcare Facilities-0.79%
Managed Healthcare6.54%
Healthcare Distributors3.58%
Healthcare Services3.31%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PACS PACS GroupUS$32.145.1%
+US$243.6m		236.9%PE26.4x
ACHC Acadia Healthcare CompanyUS$23.964.6%
+US$96.6m		-12.5%PS0.7x
SGRY Surgery PartnersUS$12.186.0%
+US$88.5m		-42.3%PS0.5x
NUTX Nutex HealthUS$100.927.6%
+US$49.5m		41.4%PE9.9x
BKD Brookdale Senior LivingUS$13.950.9%
+US$30.9m		140.1%PS1.1x

Latest News

SGRY
US$12.18
Surgery Partners
7D
6.0%
1Y
-42.3%

SGRY: Margin Repair And Payer Mix Management Will Support A Constructive 2026 Reset

The analyst price target for Surgery Partners has been reduced from about $25.45 to about $18.80. Analysts cite weaker Q4 EBITDA, margin pressure from a tougher payer and insurance mix, anesthesia-related cost pressures, and more cautious 2026 guidance as key drivers of their updated views.
ENSG
US$196.62
Ensign Group
7D
-2.0%
1Y
52.0%
NHC
US$162.75
National HealthCare
7D
1.1%
1Y
75.2%
BKD
US$13.95
Brookdale Senior Living
7D
0.9%
1Y
140.1%

BKD: Reaffirmed Guidance And EBITDA Stability Will Drive The Next Phase

Analysts have lifted their price targets on Brookdale Senior Living, with one recent update moving from $18.00 to $19.50. They cite reaffirmed guidance, steady adjusted EBITDA estimates, and what they view as strong underlying trends in the business.
CON
US$20.89
Concentra Group Holdings Parent
7D
-1.1%
1Y
1.4%

CON: New Clinics And M&A Pipeline Will Support Future Earnings Power

Analysts have kept their price target for Concentra Group Holdings Parent steady at $29.00. This reflects minor tweaks to assumptions around discount rate, profit margin and future P/E expectations rather than a shift in overall valuation view.
THC
US$188.17
Tenet Healthcare
7D
-1.9%
1Y
56.4%
ACHC
US$23.96
Acadia Healthcare Company
7D
4.6%
1Y
-12.5%

ACHC: Medicaid Pressure And Execution Risks Will Drive Shares Lower

Analysts have lifted their average price targets on Acadia Healthcare into a broad $20 to $28 range, and the updated fair value estimate has shifted to $13.69 as models now reflect more moderate revenue growth and profit margins, along with a higher assumed future P/E multiple. Analyst Commentary Recent Street research on Acadia Healthcare presents a mixed picture, with several firms raising price targets into the low to high $20s while a few bearish analysts are trimming targets or turning more cautious ahead of upcoming results.
UHS
US$176.70
Universal Health Services
7D
-4.0%
1Y
1.2%

UHS: Future Volumes And Policy Risk Will Drive Upside From Buybacks

Analyst price targets for Universal Health Services have edged lower by $1.65. This reflects mixed views on weaker recent acute results, guidance that aligns with consensus but assumes stronger future volumes, and differing opinions on the impact of policy changes and payor mix risk.
EHC
US$97.39
Encompass Health
7D
-0.2%
1Y
-0.6%

EHC: Hospital Expansion And Steady Profitability Assumptions Will Support Future Upside

Analysts have increased their price target on Encompass Health by $3, citing updated assumptions around revenue growth, profit margins, and the future P/E ratio that leave their overall fair value view broadly unchanged. Analyst Commentary Bullish Takeaways Bullish analysts view the $3 price target increase as a reflection of updated assumptions around revenue, margins, and future P/E that still support the current valuation framework.
SNDA
US$32.18
Sonida Senior Living
7D
1.7%
1Y
48.0%

Acquisition Synergies And Portfolio Pruning Will Reshape Senior Housing Platform Over Time

Catalysts About Sonida Senior Living Sonida Senior Living owns and operates senior housing communities, with a focus on assisted living and related care services. What are the underlying business or industry changes driving this perspective?
HCA
US$471.84
HCA Healthcare
7D
-0.002%
1Y
42.3%

HCA: Future Upside Will Center On Georgia Medicaid SDP Earnings Support

HCA Healthcare's analyst price targets have moved higher by a broad range that stretches into the mid $600s, reflecting analysts' updated models around Georgia's newly approved $1.9b Medicaid SDP program and potential efficiency gains from AI that could influence valuation multiples. Analyst Commentary Recent Street research around HCA Healthcare centers on two themes that matter for valuation: the newly approved Georgia Medicaid SDP program and potential AI driven efficiency gains.
NUTX
US$100.92
Nutex Health
7D
7.6%
1Y
41.4%

NUTX: Share Repurchases Will Support Future Upside Potential

Analysts have adjusted their price target on Nutex Health from $241.67 to $221.67, reflecting updated views on revenue growth, profit margins, and a lower assumed future P/E multiple. What's in the News Nutex Health completed a previously announced buyback program, repurchasing 27,870 shares, representing 0.4% of the company, for a total of $4.95 million between October 1, 2025 and December 31, 2025 (Key Developments).
TOI
US$3.12
Oncology Institute
7D
5.4%
1Y
131.1%
USPH
US$73.74
U.S. Physical Therapy
7D
-1.4%
1Y
9.9%
PACS
US$32.14
PACS Group
7D
5.1%
1Y
236.9%